Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

Xueling Wu(National Institutes of Health), Tongqing Zhou(National Institutes of Health), Jiang Zhu(National Institutes of Health), Baoshan Zhang(National Institutes of Health), Ivelin S. Georgiev(National Institutes of Health), Charlene Wang(National Institutes of Health), Xuejun Chen(National Institutes of Health), Nancy S. Longo(National Institutes of Health), Mark K. Louder(National Institutes of Health), Krisha McKee(National Institutes of Health), Sijy O’Dell(National Institutes of Health), Stephen P. Perfetto(National Institutes of Health), Stephen D. Schmidt(National Institutes of Health), Wei Shi(National Institutes of Health), Lan Wu(National Institutes of Health), Yongping Yang(National Institutes of Health), Zhiyong Yang(National Institutes of Health), Ziying Yang(National Institutes of Health), Zhenhai Zhang(National Institutes of Health), Mattia Bonsignori(Duke University), John A. Crump(Duke University), Saidi Kapiga(Kilimanjaro Christian Medical Centre), Noel E. Sam(Christian Medical College, Vellore), Barton F. Haynes(Duke University), Melissa Simek(International AIDS Vaccine Initiative), Dennis R. Burton(Scripps Research Institute), Wayne C. Koff(International AIDS Vaccine Initiative), Nicole A. Doria‐Rose(National Institutes of Health), Mark Connors(National Institutes of Health), NISC Comparative Sequencing Program(National Institutes of Health), James C. Mullikin(National Institutes of Health), Gary J. Nabel(National Institutes of Health), Mario Roederer(National Institutes of Health), Lawrence Shapiro(National Institutes of Health), Peter D. Kwong(National Institutes of Health), John R. Mascola(National Institutes of Health)
Science
August 12, 2011
Cited by 813

Abstract

Antibody VRC01 is a human immunoglobulin that neutralizes about 90% of HIV-1 isolates. To understand how such broadly neutralizing antibodies develop, we used x-ray crystallography and 454 pyrosequencing to characterize additional VRC01-like antibodies from HIV-1-infected individuals. Crystal structures revealed a convergent mode of binding for diverse antibodies to the same CD4-binding-site epitope. A functional genomics analysis of expressed heavy and light chains revealed common pathways of antibody-heavy chain maturation, confined to the IGHV1-2*02 lineage, involving dozens of somatic changes, and capable of pairing with different light chains. Broadly neutralizing HIV-1 immunity associated with VRC01-like antibodies thus involves the evolution of antibodies to a highly affinity-matured state required to recognize an invariant viral structure, with lineages defined from thousands of sequences providing a genetic roadmap of their development.


Related Papers

No related papers found

Powered by citation graph analysis